Ding Ren Shen
Jiangsu Province Hospital(CN)Nanjing Medical University(CN)
Publications by Year
Research Areas
Sphingolipid Metabolism and Signaling, Protein Kinase Regulation and GTPase Signaling, Cytokine Signaling Pathways and Interactions, Melanoma and MAPK Pathways, Advanced biosensing and bioanalysis techniques
Most-Cited Works
- → Disruption of insulin–like growth factor 2 imprinting in Beckwith–Wiedemann syndrome(1993)424 cited
- → 2-Aminothiazole as a Novel Kinase Inhibitor Template. Structure−Activity Relationship Studies toward the Discovery of N -(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (Dasatinib, BMS-354825) as a Potent pan -Src Kinase Inhibitor(2006)395 cited
- → Discovery of 2-amino-heteroaryl-benzothiazole-6-anilides as potent p56lck inhibitors(2003)106 cited
- → Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors(2015)88 cited
- → Design, Synthesis, and Anti-inflammatory Properties of Orally Active 4-(Phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38α Mitogen-Activated Protein Kinase Inhibitors(2007)81 cited
- → 5-Cyanopyrimidine Derivatives as a Novel Class of Potent, Selective, and Orally Active Inhibitors of p38α MAP Kinase(2005)